The following will give you some idea of the potential earnings for ETCR !
Example of Volume Projections The Commonwealth of Kentucky collected 19 million fill records in 27 months of KASPER (“Kentucky All Schedule Prescription Electronic Reporting”) operation. Below are the projections from that data: Factor Value Total KASPER Transactions 19,000,000 KASPER Months 27 Fills per Month 703,703 Kentucky Pharmacists* 3,046 Fills per Pharmacist/Month 231 Kentucky Practitioners* 13,830 Fills per Practitioner/Month 51 Fills per Prescription Written 1.5 (est.) Prescriptions/Practitioner/Month 34
Extrapolating the KASPER data to all diversion-tracking states provides the following results: Factor Value Practitioners* 421,389 Pharmacists* 91,729 Prescriptions Written per Month 14,327,226 Fills per Month 21,189,399 Total Transactions per Month 35,516,625
Which is roughly: 426199500 Yearly If charged .25/transaction and ETCR gets 25% of that revenue...then its about $26 million almost all of which is total profit on the books of ETCR...
Finally, reading the business model one see's that the revenue model is not based soley on prescriptions. That is merely phase 1. They fully intend to provide other valuable services on a subscription basis.
This is an area of much more competition. However we will have an advantage over competition in that we will already be "in house", providing an insurance discount, etc...the sale of the new services will boost revenue much further over the coming years. We may even see some partnerships with existing companies in this area down the road...or be purchased by them..etc...
All my own opinion...but based on the business plan model on the company website...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.